{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:54:07Z","timestamp":1791518047804,"version":"4.3.4"},"reference-count":210,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00432","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T11:43:46Z","timestamp":1477050226000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Unraveling the Role of Allo-Antibodies and Transplant Injury"],"prefix":"10.3389","volume":"7","author":[{"given":"Yoshiko","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minnie M.","family":"Sarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0065-2776(08)60308-9","article-title":"Cell-mediated cytotoxicity, allograft rejection, and tumor immunity","volume":"18","author":"Cerottini","year":"1974","journal-title":"Adv Immunol"},{"issue":"8","key":"B2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/eji.1830110812","article-title":"Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2","volume":"11","author":"Bunjes","year":"1981","journal-title":"Eur J Immunol"},{"issue":"2","key":"B3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"issue":"11","key":"B4","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"issue":"8","key":"B5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/00007890-200104270-00017","article-title":"Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques","volume":"71","author":"Piazza","year":"2001","journal-title":"Transplantation"},{"issue":"14","key":"B6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"issue":"2","key":"B7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1600-6143.2007.02072.x","article-title":"Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation","volume":"8","author":"Lefaucheur","year":"2008","journal-title":"Am J Transplant"},{"issue":"8","key":"B8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/TP.0b013e3182483713","article-title":"A personal perspective: 100-year history of the humoral theory of transplantation","volume":"93","author":"Terasaki","year":"2012","journal-title":"Transplantation"},{"issue":"1","key":"B9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Zeevi","year":"2012","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"B10","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1097\/TP.0b013e3182157d60","article-title":"HLA and MICA: targets of antibody-mediated rejection in heart transplantation","volume":"91","author":"Zhang","year":"2011","journal-title":"Transplantation"},{"issue":"2","key":"B11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1432-2277.2010.01166.x","article-title":"Significance of qualitative and quantitative evaluations of anti-HLA antibodies in kidney transplantation","volume":"24","author":"Ishida","year":"2011","journal-title":"Transpl Int"},{"issue":"3","key":"B12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/TP.0b013e31817c4cb8","article-title":"Human leukocyte antigen antibodies and chronic rejection: from association to causation","volume":"86","author":"Terasaki","year":"2008","journal-title":"Transplantation"},{"issue":"8","key":"B13","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1097\/00007890-200210270-00025","article-title":"All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies","volume":"74","author":"Lee","year":"2002","journal-title":"Transplantation"},{"issue":"15","key":"B14","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMra0902927","article-title":"Rejection of the kidney allograft","volume":"363","author":"Nankivell","year":"2010","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"B16","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/ajt.13721","article-title":"Therapeutics for antibody-mediated rejection: a slippery slope into confusion","volume":"16","author":"Montgomery","year":"2016","journal-title":"Am J Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"970421","DOI":"10.1155\/2011\/970421","article-title":"ABO incompatible kidney transplantation-current status and uncertainties","volume":"2011","author":"Shin","year":"2011","journal-title":"J Transplant"},{"issue":"3","key":"B18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1600-6143.2008.02538.x","article-title":"Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors","volume":"9","author":"Toki","year":"2009","journal-title":"Am J Transplant"},{"issue":"9","key":"B19","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/lt.23687","article-title":"Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation","volume":"19","author":"O\u2019Leary","year":"2013","journal-title":"Liver Transpl"},{"issue":"6","key":"B20","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"issue":"9","key":"B21","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/TP.0000000000000672","article-title":"Association of kidney graft loss with de novo produced donor-specific and non-donor-specific HLA antibodies detected by single antigen testing","volume":"99","author":"S\u00fcsal","year":"2015","journal-title":"Transplantation"},{"issue":"4","key":"B22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/TP.0000000000000071","article-title":"Analysis of predictive and preventive factors for de novo DSA in kidney transplant recipients","volume":"98","author":"Hirai","year":"2014","journal-title":"Transplantation"},{"issue":"12","key":"B23","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1111\/ajt.13407","article-title":"De novo donor-specific HLA antibodies are associated with rapid loss of graft function following islet transplantation in type 1 diabetes","volume":"15","author":"Brooks","year":"2015","journal-title":"Am J Transplant"},{"issue":"4","key":"B24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.transproceed.2012.12.026","article-title":"The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome","volume":"45","author":"Banasik","year":"2013","journal-title":"Transplant Proc"},{"issue":"3","key":"B25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/TP.0b013e3181bbbe4c","article-title":"Compartmental localization and clinical relevance of MICA antibodies after renal transplantation","volume":"89","author":"Li","year":"2010","journal-title":"Transplantation"},{"issue":"3","key":"B26","doi-asserted-by":"publisher","first-page":"M110.000497","DOI":"10.1074\/mcp.M110.000497","article-title":"Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease","volume":"10","author":"Butte","year":"2011","journal-title":"Mol Cell Proteomics"},{"issue":"11","key":"B27","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1073\/pnas.0900563106","article-title":"Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and \u201cantibodyome\u201d measures","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"B28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.coi.2008.07.005","article-title":"Relevance of MICA and other non-HLA antibodies in clinical transplantation","volume":"20","author":"Sumitran-Holgersson","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"9470","key":"B29","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/S0140-6736(05)66458-6","article-title":"Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies","volume":"365","author":"Opelz","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"B30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1681\/ASN.2011060596","article-title":"Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury","volume":"23","author":"Sigdel","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"B31","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1021\/pr1008674","article-title":"Differential immunogenicity and clinical relevance of kidney compartment specific antigens after renal transplantation","volume":"9","author":"Li","year":"2010","journal-title":"J Proteome Res"},{"issue":"6","key":"B32","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/TP.0b013e31819a65fa","article-title":"A reevaluation of the role of IgM non-HLA antibodies in cardiac transplantation","volume":"87","author":"Smith","year":"2009","journal-title":"Transplantation"},{"issue":"2","key":"B33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1034\/j.1600-6143.2003.00021.x","article-title":"Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis","volume":"3","author":"Le Bas-Bernardet","year":"2003","journal-title":"Am J Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri1834","article-title":"Viral immunity: turning off class switching","volume":"6","author":"Amoils","year":"2000","journal-title":"Nat Rev Immunol"},{"issue":"24","key":"B36","doi-asserted-by":"publisher","first-page":"12950","DOI":"10.1073\/pnas.97.24.12950","article-title":"A novel helper role for CD4 T cells","volume":"97","author":"den Haan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"B37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J Exp Med"},{"issue":"6","key":"B38","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1084\/jem.183.6.2541","article-title":"CTLA-4 ligation blocks CD28-dependent T cell activation","volume":"183","author":"Walunas","year":"1996","journal-title":"J Exp Med"},{"issue":"5","key":"B39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","article-title":"CTLA-4 can function as a negative regulator of T cell activation","volume":"1","author":"Walunas","year":"1994","journal-title":"Immunity"},{"issue":"5238","key":"B40","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4","volume":"270","author":"Waterhouse","year":"1995","journal-title":"Science"},{"issue":"22","key":"B41","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1182\/blood-2011-11-388918","article-title":"Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells","volume":"119","author":"Tai","year":"2012","journal-title":"Blood"},{"issue":"4","key":"B42","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1073\/pnas.0910341107","article-title":"Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity","volume":"107","author":"Jain","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"B43","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int Immunol"},{"issue":"2","key":"B44","first-page":"273","article-title":"Association of HLA class II alleles and CTLA-4 polymorphism with type 1 diabetes","volume":"22","author":"Ei Wafai","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4172\/2155-6156.1000291","article-title":"Association of CTLA-4 polymorphisms with type 1 diabetes in the Egyptian population diabetes & metabolism","volume":"4","author":"Mohamed Saleh","year":"2013","journal-title":"J Diabetes Metab"},{"key":"B46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2350-14-46","article-title":"The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves\u2019 disease in the Chinese population","volume":"14","author":"Du","year":"2013","journal-title":"BMC Med Genet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nri1248","article-title":"CD28-mediated co-stimulation: a quantitative support for TCR signalling","volume":"3","author":"Acuto","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"B48","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1084\/jem.173.3.721","article-title":"Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation","volume":"173","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"issue":"7","key":"B49","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1084\/jem.20110040","article-title":"Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells","volume":"208","author":"Rozanski","year":"2011","journal-title":"JEM"},{"key":"B50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"van Kooten","year":"2000","journal-title":"J Leukocyte Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic-T-cell responses is mediated by CD40 signalling","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.4049\/jimmunol.175.12.7867","article-title":"IL-21 induces differentiation of human na\u00efve and memory B cells into antibody-secreting plasma cells","volume":"175","author":"Ettinger","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"B54","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.4049\/jimmunol.1300830","article-title":"CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-\u03b2","volume":"191","author":"Deppong","year":"2013","journal-title":"J Immunol"},{"issue":"8","key":"B55","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/ajt.13761","article-title":"Delayed CTLA4-Ig treatment reverses ongoing alloantibody responses and rescues allografts from acute rejection","volume":"16","author":"Young","year":"2016","journal-title":"Am J Transplant"},{"issue":"26","key":"B56","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"B58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00395-016-0554-5","article-title":"CD40 in coronary artery disease: a matter of macrophages?","volume":"111","author":"Jansen","year":"2016","journal-title":"Basic Res Cardiol"},{"issue":"256","key":"B59","doi-asserted-by":"publisher","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Transl Med"},{"issue":"19","key":"B60","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3978\/j.issn.2305-5839.2015.11.08","article-title":"Circulating CD40 autoantibody and suPAR synergy drives glomerular injury","volume":"3","author":"Wei","year":"2015","journal-title":"Ann Transl Med"},{"issue":"3","key":"B61","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1586\/1744666X.4.3.391","article-title":"Trends in HLA antibody screening and identification and their role in transplantation","volume":"4","author":"Murphey","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"key":"B62","first-page":"1","article-title":"The UNOS scientific renal transplant registry","author":"Cecka","year":"1997","journal-title":"Clin Transpl"},{"issue":"15","key":"B63","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJM200010123431504","article-title":"Twelve years\u2019 experience with national sharing of HLA-matched cadaveric kidneys for transplantation","volume":"343","author":"Takemoto","year":"2000","journal-title":"N Engl J Med"},{"issue":"15","key":"B64","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1056\/NEJM199104113241505","article-title":"National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs","volume":"324","author":"Gjertson","year":"1991","journal-title":"N Engl J Med"},{"issue":"3","key":"B65","first-page":"1144","article-title":"Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival","volume":"28","author":"Terasaki","year":"1996","journal-title":"Transplant Proc"},{"issue":"7","key":"B66","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1111\/ajt.12750","article-title":"De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure","volume":"14","author":"Mittal","year":"2014","journal-title":"Am J Transplant"},{"issue":"12","key":"B67","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1111\/j.1600-6143.2011.03729.x","article-title":"Post transplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome","volume":"11","author":"Cantarovich","year":"2011","journal-title":"Am J Transplant"},{"key":"B68","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.trre.2009.02.005","article-title":"Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection","volume":"23","author":"Murata","year":"2009","journal-title":"Transplant Rev"},{"issue":"3","key":"B69","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/00007890-198503000-00016","article-title":"The vascular endothelial cell antigen system","volume":"39","author":"Cerilli","year":"1985","journal-title":"Transplantation"},{"issue":"4","key":"B70","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/ajt.12667","article-title":"The role of donor-specific HLA alloantibodies in liver transplantation","volume":"14","author":"O\u2019Leary","year":"2014","journal-title":"Am J Transplant"},{"issue":"3","key":"B71","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/MOT.0b013e3283614a10","article-title":"Impact of donor-specific antibodies on results of liver transplantation","volume":"18","author":"O\u2019Leary","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"issue":"Suppl 4","key":"B72","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.healun.2013.01.191","article-title":"HLA antibodies after lung transplantation: early results of the HALT study","volume":"32","author":"Hachem","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"B73","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1164\/rccm.201312-2160OC","article-title":"Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates","volume":"189","author":"Kim","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"B74","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"issue":"12","key":"B75","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.healun.2014.06.015","article-title":"Early donor-specific antibodies in lung transplantation: risk factors and impact on survival","volume":"33","author":"Ius","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"B76","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/ajt.13079","article-title":"What is the definition of a clinically relevant donor HLA-specific antibody (DSA)?","volume":"15","author":"Hachem","year":"2015","journal-title":"Am J Transplant"},{"issue":"11","key":"B77","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015461","article-title":"Effector mechanisms of rejection","volume":"3","author":"Moreau","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s40265-015-0369-y","article-title":"Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management","volume":"75","author":"Ng","year":"2015","journal-title":"Drugs"},{"issue":"6","key":"B79","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1086\/597089","article-title":"Infectious complications of antilymphocyte therapies in solid organ transplantation","volume":"48","author":"Issa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B80","first-page":"107","volume-title":"Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplantation","year":"2013","edition":"3rd Edition"},{"issue":"15","key":"B81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jneuroim.2015.11.006","article-title":"Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination","volume":"290","author":"Maurer","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000444250","article-title":"Acute respiratory distress syndrome and posterior reversible encephalopathy syndrome following rituximab therapy","volume":"6","author":"Wardrope","year":"2016","journal-title":"Case Rep Nephrol Dial"},{"issue":"12","key":"B83","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"B84","first-page":"465","article-title":"Successful treatment with bortezomib of a refractory humoral rejection of the intestine after multivisceral transplantation","author":"Island","year":"2009","journal-title":"Clin Transpl"},{"key":"B85","first-page":"475","article-title":"Bortezomib for refractory antibody-mediated cardiac allograft rejection","author":"Eckman","year":"2009","journal-title":"Clin Transpl"},{"key":"B86","first-page":"443","article-title":"Bortezomib-based treatment of antibody mediated rejection in pancreas allograft recipients","author":"Govil","year":"2009","journal-title":"Clin Transpl"},{"key":"B87","first-page":"339","article-title":"Bortezomib in kidney transplant desensitization: a case report","author":"Raghavan","year":"2009","journal-title":"Clin Transpl"},{"key":"B88","first-page":"387","article-title":"Bortezomib affects the function of human B cells: possible implications for desensitization protocols","author":"Heidt","year":"2009","journal-title":"Clin Transpl"},{"issue":"2","key":"B89","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.trsl.2014.10.010","article-title":"Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome","volume":"165","author":"Wong","year":"2015","journal-title":"Transl Res"},{"issue":"10","key":"B90","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00467-011-1929-3","article-title":"Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy","volume":"26","author":"Bouts","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"B91","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7224\/1537-2073.2014-030","article-title":"Prevention and management of infusion-associated reactions in the comparison of alemtuzumab and rebif(\u00ae) efficacy in multiple sclerosis (CARE-MS) program","volume":"17","author":"Caon","year":"2015","journal-title":"Int J MS Care"},{"issue":"2 Suppl 5","key":"B92","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1053\/j.seminoncol.2006.01.027","article-title":"Strategies in the management of alemtuzumab-related side effects","volume":"33","author":"Osterborg","year":"2006","journal-title":"Semin Oncol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1517\/14656566.2010.492395","article-title":"Strategies for managing cytomegalovirus in transplant recipients","volume":"11","author":"Razonable","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"B94","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/jmv.23539","article-title":"High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy","volume":"85","author":"Harvala","year":"2013","journal-title":"J Med Virol"},{"issue":"11","key":"B95","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1086\/324516","article-title":"Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir","volume":"184","author":"Razonable","year":"2001","journal-title":"J Infect Dis"},{"issue":"3","key":"B96","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1128\/JCM.40.3.746-752.2002","article-title":"Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients","volume":"40","author":"Razonable","year":"2002","journal-title":"J Clin Microbiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"B98","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"AST infectious diseases community of practice. Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"B99","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40","volume":"71","author":"Knowles","year":"2003","journal-title":"J Med Virol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors","volume":"199","author":"Egli","year":"2009","journal-title":"J Infect Dis"},{"key":"B101","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJM200005043421802","article-title":"Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy","volume":"342","author":"Nickeleit","year":"2000","journal-title":"N Engl J Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/01.tp.0000269706.59977.a5","article-title":"Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation","volume":"84","author":"Drachenberg","year":"2007","journal-title":"Transplantation"},{"key":"B104","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/01.tp.0000275205.41078.51","article-title":"Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy","volume":"84","author":"Viscount","year":"2007","journal-title":"Transplantation"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1097\/01.ASN.0000023435.07320.81","article-title":"Clinical course of polyoma virus nephropathy in 67 renal transplant patients","volume":"13","author":"Ramos","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"B106","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1600-6143.2006.01296.x","article-title":"Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN)","volume":"6","author":"Wadei","year":"2006","journal-title":"Am J Transplant"},{"issue":"2","key":"B107","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jmv.23472","article-title":"Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients","volume":"85","author":"Antonsson","year":"2013","journal-title":"J Med Virol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00007890-199901150-00018","article-title":"Human polyoma virus-associated interstitial nephritis in the allograft kidney","volume":"67","author":"Randhawa","year":"1999","journal-title":"Transplantation"},{"key":"B109","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/00007890-199903270-00022","article-title":"Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss","volume":"67","author":"Binet","year":"1999","journal-title":"Transplantation"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirusassociated nephropathy","volume":"10","author":"Schaub","year":"2010","journal-title":"Am J Transplant"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1111\/j.1600-6143.2007.01984.x","article-title":"Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients","volume":"7","author":"Ginevri","year":"2007","journal-title":"Am J Transplant"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker","year":"1995","journal-title":"Clin Infect Dis"},{"key":"B113","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1034\/j.1600-6143.2001.001002103.x","article-title":"Management of Epstein-Barr virus-induced posttransplant lymphoproliferative disease in recipients of solid organ transplantation","volume":"1","author":"Green","year":"2001","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"B114","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/cvr\/cvu098.180","article-title":"P761Antibody mediated rejection related with CMV and EBV infection in heart transplants recipients: a possible relation with infection and complement activation","volume":"103","author":"Fedrigo","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"3\u20134","key":"B115","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.trim.2009.12.005","article-title":"Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant","volume":"22","author":"Marrari","year":"2010","journal-title":"Transpl Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"845040","DOI":"10.1155\/2014\/845040","article-title":"Clinical relevance of HLA antibody monitoring after kidney transplantation","volume":"2014","author":"Morath","year":"2014","journal-title":"J Immunol Res"},{"issue":"10","key":"B117","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nri1203","article-title":"Plasma-cell homing","volume":"3","author":"Kunkel","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"B118","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1084\/jem.194.1.45","article-title":"A coordinated change in chemokine responsiveness guides plasma cell movements","volume":"194","author":"Hargreaves","year":"2001","journal-title":"J Exp Med"},{"issue":"5447","key":"B119","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1126\/science.286.5447.2098","article-title":"Chemokines and cell migration in secondary lymphoid organs","volume":"286","author":"Cyster","year":"1999","journal-title":"Science"},{"key":"B120","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1182\/blood-2009-07-235960","article-title":"An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization","volume":"114","author":"Jourdan","year":"2009","journal-title":"Blood"},{"issue":"2","key":"B121","first-page":"573","article-title":"Memory B cells and CD27","volume":"15","author":"Agematsu","year":"2000","journal-title":"Histol Histopathol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fimmu.2011.00081","article-title":"The relationship between CD27 negative and positive B cell populations in human peripheral blood","volume":"2","author":"Wu","year":"2011","journal-title":"Front Immunol"},{"issue":"27","key":"B123","doi-asserted-by":"publisher","first-page":"12192","DOI":"10.1073\/pnas.1005443107","article-title":"Preferential localization of IgG memory B cells adjacent to contracted germinal centers","volume":"107","author":"Aiba","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"B124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.humimm.2008.10.013","article-title":"Peripheral blood B cells producing donor-specific HLA antibodies in vitro","volume":"70","author":"Han","year":"2009","journal-title":"Hum Immunol"},{"issue":"1","key":"B125","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.immuni.2013.06.011","article-title":"Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation","volume":"39","author":"Kometani","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"B126","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived PCs","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"issue":"1","key":"B127","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00912.x","article-title":"Mechanisms that determine plasma cell lifespan and the duration of humoral immunity","volume":"236","author":"Amanna","year":"2010","journal-title":"Immunol Rev"},{"issue":"3","key":"B128","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","article-title":"Long-lived autoreactive PCs drive persistent autoimmune inflammation","volume":"7","author":"Hiepe","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"B129","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.autrev.2010.12.007","article-title":"Factors implicated in the generation and persistence of long-lived plasma cell-mediated autoimmunity","volume":"10","author":"Mei","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B130","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/01.TP.0000441826.70687.f6","article-title":"Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone","volume":"97","author":"Haneda","year":"2014","journal-title":"Transplantation"},{"issue":"12","key":"B131","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","article-title":"Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells","volume":"179","author":"Bryant","year":"2007","journal-title":"J Immunol"},{"issue":"4","key":"B132","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.4049\/jimmunol.1201678","article-title":"IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells","volume":"190","author":"Ding","year":"2013","journal-title":"J Immunol"},{"issue":"4","key":"B133","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1182\/blood-2006-03-008441","article-title":"CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells","volume":"109","author":"Huggins","year":"2007","journal-title":"Blood"},{"issue":"3","key":"B134","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1182\/blood-2007-09-110874","article-title":"TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts","volume":"11","author":"Bossen","year":"2008","journal-title":"Blood"},{"issue":"1","key":"B135","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O\u2019Connor","year":"2004","journal-title":"J Exp Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1172\/JCI18025","article-title":"BAFF selectively enhances the survival of plasmablasts generated from human memory B cells","volume":"112","author":"Avery","year":"2003","journal-title":"J Clin Invest"},{"issue":"5","key":"B137","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin Immunol"},{"issue":"12","key":"B138","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.4049\/jimmunol.1103720","article-title":"In vitro generation of long-lived human PCs","volume":"189","author":"Cocco","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"B139","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-3083.2011.02544.x","article-title":"The long-term survival of PCs","volume":"73","author":"Chu","year":"2011","journal-title":"Scand J Immunol"},{"issue":"4","key":"B140","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0952-7915(02)00356-4","article-title":"Humoral immunity and long-lived PCs","volume":"14","author":"Manz","year":"2002","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"B141","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.4049\/jimmunol.1103169","article-title":"Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell niche","volume":"188","author":"Belnoue","year":"2012","journal-title":"J Immunol"},{"issue":"12","key":"B142","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.it.2011.09.001","article-title":"Staying alive: regulation of plasma cell survival","volume":"32","author":"Tangye","year":"2011","journal-title":"Trends Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev.immunol.23.021704.115732","article-title":"Antigen-specific memory B cell development","volume":"23","author":"McHeyzer-Williams","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"B144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12026-015-8669-6","article-title":"The role of complement activation in atherogenesis: the first 40 years","volume":"64","author":"Vlaicu","year":"2016","journal-title":"Immunol Res"},{"issue":"6","key":"B145","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0031-3955(05)70274-1","article-title":"Complement deficiencies","volume":"47","author":"Frank","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"B146","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.humimm.2013.08.103","article-title":"C1q assay: making sense of sensitivity","volume":"74","author":"Lopez-Cepero","year":"2013","journal-title":"Hum Immunol"},{"issue":"7","key":"B147","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1097\/TP.0000000000000525","article-title":"Factors predicting risk for antibody-mediated rejection and graft loss in highly human leukocyte antigen sensitized patients transplanted after desensitization","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"issue":"7","key":"B148","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00467-016-3322-8","article-title":"Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients","volume":"31","author":"Fichtner","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"B150","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts","volume":"26","author":"Loupy","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"B151","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/TP.0000000000000183","article-title":"The histology of kidney transplant failure: a long-term follow-up study","volume":"98","author":"Naesens","year":"2014","journal-title":"Transplantation"},{"issue":"1","key":"B152","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/TP.0b013e31829434d4","article-title":"Early versus late acute antibody-mediated rejection in renal transplant recipients","volume":"96","author":"D\u00f6rje","year":"2013","journal-title":"Transplantation"},{"issue":"8","key":"B153","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.2215\/CJN.09901014","article-title":"Capillary C4d and kidney allograft outcome in relation to morphologic lesions suggestive of antibody-mediated rejection","volume":"10","author":"Kiki\u0107","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"B154","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/TP.0000000000000448","article-title":"De novo donor-specific human leukocyte antigen antibodies in nonsensitized kidney transplant recipients after T cell-mediated rejection","volume":"99","author":"Chemouny","year":"2015","journal-title":"Transplantation"},{"issue":"8","key":"B155","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.transproceed.2015.09.018","article-title":"Plasma cell-rich rejection after kidney transplantation and the role of donor-specific antibodies: a case report and review of the literature","volume":"47","author":"Hasegawa","year":"2015","journal-title":"Transplant Proc"},{"issue":"2","key":"B156","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40472-015-0061-x","article-title":"Diagnosis and treatment of pancreas rejection","volume":"2","author":"Redfield","year":"2015","journal-title":"Curr Transplant Rep"},{"issue":"4","key":"B157","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/ajt.13153","article-title":"Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation","volume":"15","author":"O\u2019Leary","year":"2015","journal-title":"Am J Transplant"},{"issue":"6","key":"B158","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"B159","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.healun.2012.10.007","article-title":"Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation","volume":"32","author":"Lobo","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"B160","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/ajt.13529","article-title":"Late failing heart allografts: pathology of cardiac allograft vasculopathy and association with antibody-mediated rejection","volume":"16","author":"Loupy","year":"2016","journal-title":"Am J Transplant"},{"issue":"8","key":"B161","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/TP.0000000000000614","article-title":"Prospective monitoring of donor-specific anti-HLA antibodies after intestine\/multivisceral transplantation: significance of de novo antibodies","volume":"99","author":"Kubal","year":"2015","journal-title":"Transplantation"},{"issue":"6","key":"B162","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/TP.0b013e318229f752","article-title":"Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation","volume":"92","author":"Tsai","year":"2011","journal-title":"Transplantation"},{"issue":"11","key":"B163","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"issue":"3","key":"B164","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1365-2249.1991.tb02954.x","article-title":"Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection","volume":"86","author":"Feucht","year":"1991","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"B165","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrneph.2012.212","article-title":"The role of complement in antibody-mediated rejection in kidney transplantation","volume":"8","author":"Stegall","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ncpneph0133","article-title":"Drug insight: rituximab in renal disease and transplantation","volume":"2","author":"Salama","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"issue":"1","key":"B167","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"B168","first-page":"199","article-title":"Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation","volume":"117","author":"Jordan","year":"2006","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"3","key":"B169","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"issue":"3","key":"B170","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MOT.0b013e32835d4daf","article-title":"Pathology of C4d-negative antibody-mediated rejection in renal allografts","volume":"18","author":"Haas","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"B171","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff meeting report writing committee. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"issue":"3","key":"B172","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2215\/CJN.01881105","article-title":"Antibody-mediated rejection in renal allografts: lessons from pathology","volume":"1","author":"Racusen","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/ki.2011.497","article-title":"Pros and cons for C4d as a biomarker","volume":"81","author":"Cohen","year":"2012","journal-title":"Kidney Int"},{"issue":"2","key":"B174","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00007890-198508000-00001","article-title":"Vascular endothelial alloantigens in renal transplantation","volume":"40","author":"Paul","year":"1985","journal-title":"Transplantation"},{"issue":"4","key":"B175","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/00007890-198810000-00024","article-title":"Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with a negative monocyte crossmatch","volume":"46","author":"Jordan","year":"1988","journal-title":"Transplantation"},{"issue":"9470","key":"B176","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/S0140-6736(05)66458-6","article-title":"Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies","volume":"365","author":"Opelz","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"B177","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0966-3274(97)80016-0","article-title":"Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells","volume":"5","author":"Sumitran-Karuppan","year":"1997","journal-title":"Transpl Immunol"},{"issue":"1","key":"B178","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"issue":"6","key":"B179","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1034\/j.1600-6143.2003.00135.x","article-title":"Humoral theory of transplantation","volume":"3","author":"Terasaki","year":"2003","journal-title":"Am J Transplant"},{"issue":"4","key":"B180","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.humimm.2005.01.021","article-title":"Humoral theory of transplantation: mechanism, prevention, and treatment","volume":"66","author":"Cai","year":"2005","journal-title":"Hum Immunol"},{"issue":"9","key":"B181","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.transproceed.2007.08.054","article-title":"Variability in donor-specific alloantibody production after transplantation","volume":"39","author":"Banasik","year":"2007","journal-title":"Transplant Proc"},{"issue":"4","key":"B182","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.transproceed.2012.12.026","article-title":"The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome","volume":"45","author":"Banasik","year":"2013","journal-title":"Transplant Proc"},{"issue":"1\u20134","key":"B183","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trim.2013.07.002","article-title":"Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?","volume":"29","author":"Crespo","year":"2013","journal-title":"Transpl Immunol"},{"issue":"4","key":"B184","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.trim.2013.05.001","article-title":"Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death","volume":"28","author":"Fidler","year":"2013","journal-title":"Transpl Immunol"},{"issue":"11","key":"B185","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/00007890-199512000-00013","article-title":"Late acute failure of well-HLA-matched renal allografts with capillary congestion and arteriolar thrombi","volume":"60","author":"Hourmant","year":"1995","journal-title":"Transplantation"},{"key":"B186","first-page":"449","article-title":"Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants","author":"Terasaki","year":"2003","journal-title":"Clin Transpl"},{"issue":"2","key":"B187","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1399-0039.2009.01276.x","article-title":"Role of non-HLA genetic variants in end-stage renal disease","volume":"74","author":"Ranganath","year":"2009","journal-title":"Tissue Antigens"},{"issue":"12","key":"B188","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/ki.2009.384","article-title":"Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients","volume":"76","author":"Sutherland","year":"2009","journal-title":"Kidney Int"},{"issue":"5","key":"B189","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.humimm.2007.01.006","article-title":"Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes andrenal allograft loss","volume":"68","author":"Panigrahi","year":"2007","journal-title":"Hum Immunol"},{"issue":"13","key":"B190","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa067160","article-title":"Antibodies against MICA antigens and kidney-transplant rejection","volume":"357","author":"Zou","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"B191","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/00007890-200207270-00019","article-title":"Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts","volume":"74","author":"Sumitran-Holgersson","year":"2002","journal-title":"Transplantation"},{"issue":"9","key":"B192","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1111\/j.1600-6143.2005.01016.x","article-title":"Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure","volume":"5","author":"Mizutani","year":"2005","journal-title":"Am J Transplant"},{"key":"B193","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa067160","article-title":"Antibodies against MICA antigens and kidney-transplant rejection","volume":"357","author":"Zou","year":"2007","journal-title":"N Engl J Med"},{"key":"B194","doi-asserted-by":"publisher","first-page":"828201, 5","DOI":"10.1155\/2013\/828201","article-title":"Anti-HLA and anti-MICA antibodies in liver transplant recipients: effect on long-term graft survival","volume":"2013","author":"Ciszek","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"8","key":"B195","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1111\/j.1600-6143.2009.02722.x","article-title":"Lack of effect of MICA antibodies on graft survival following heart transplantation","volume":"9","author":"Smith","year":"2009","journal-title":"Am J Transplant"},{"issue":"6","key":"B196","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"B197","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/TP.0b013e3182692ad2","article-title":"Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation","volume":"94","author":"Hiemann","year":"2012","journal-title":"Transplantation"},{"issue":"8","key":"B198","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.transproceed.2014.09.029","article-title":"Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss","volume":"46","author":"Banasik","year":"2014","journal-title":"Transplant Proc"},{"issue":"7","key":"B199","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.transproceed.2008.06.014","article-title":"Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports","volume":"40","author":"Grandtnerova","year":"2008","journal-title":"Transplant Proc"},{"issue":"4","key":"B200","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/TP.0b013e3181949d4e","article-title":"Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation","volume":"87","author":"Breimer","year":"2009","journal-title":"Transplantation"},{"issue":"1","key":"B201","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/TP.0b013e31821b60e9","article-title":"Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood","volume":"92","author":"Jackson","year":"2011","journal-title":"Transplantation"},{"issue":"5","key":"B202","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1681\/ASN.2013121277","article-title":"Endothelial cell antibodies associated with novel targets and increased rejection","volume":"26","author":"Jackson","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"B203","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3904\/kjim.2001.16.1.24","article-title":"Clinical significance of anti-endothelial cell antibody in renal transplant recipients","volume":"16","author":"Shin","year":"2001","journal-title":"Korean J Intern Med"},{"issue":"5","key":"B204","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00380-015-0666-0","article-title":"Existence of circulating anti-endothelial cell antibodies after heart transplantation is associated with post-transplant acute allograft rejection","volume":"31","author":"Lehle","year":"2016","journal-title":"Heart Vessels"},{"issue":"1","key":"B205","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trim.2013.10.007","article-title":"The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes","volume":"30","author":"Banasik","year":"2014","journal-title":"Transpl Immunol"},{"issue":"6","key":"B206","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1681\/ASN.2010111183","article-title":"Antibodies reactive to non-HLA antigens in transplant glomerulopathy","volume":"22","author":"Dinavahi","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"B207","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/MOT.0b013e32834ee402","article-title":"Immunologic monitoring in transplantation revisited","volume":"17","author":"Cravedi","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"issue":"8","key":"B208","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/ctr.12567","article-title":"Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population","volume":"29","author":"Young","year":"2015","journal-title":"Clin Transplant"},{"issue":"4","key":"B209","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/iji.12202","article-title":"Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome?","volume":"42","author":"Dickinson","year":"2015","journal-title":"Int J Immunogenet"},{"issue":"4","key":"B210","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1681\/ASN.2011060596","article-title":"Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury","volume":"23","author":"Sigdel","year":"2012","journal-title":"J Am Soc Nephrol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00432\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T22:08:16Z","timestamp":1568498896000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00432\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,21]]},"references-count":210,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00432","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,21]]}}}